(Q28208386)
Statements
Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies (English)
0 references
February 2003
0 references
60
0 references
2
0 references
204-11
0 references